We were delighted to catch up with Dr Qi Cui (Scheie Eye Institute, University of Pennsylvania, PA, USA), who told us about her research on the GLP-1R agonist NLY01 and the next steps for clinical development.
- What is NLY01 and what is the rationale for its use in glaucoma therapy? (00:20)
- Could you give us an overview of your study and its findings? (01:31)
- What will be the next steps in the clinical development of NLY01? (02:46)
Speaker Disclosure: Qi Cui discloses the following: Patent (pending): Penn Center for Innovation; Sponsored Research: Neuraly, Inc., NIH/NEI K08EY029765.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of AGS 2021.
Share this Video
Related Videos In Glaucoma
Sarah Van Tassel, Kiaweh Eye 2021: Challenges and Benefits of Drug Delivery Devices in Glaucoma
We were delighted to catch up with Sarah Van Tassel (Weill Cornell Medicine, NY, USA), who shared her observations on the challenges and benefits of drug delivery devices in glaucoma, the intraocular devices currently on the market and what to watch out for in future. What are the challenges and benefits of drug delivery […]
Sarah Van Tassel, Kiaweh Eye 2021: New Drugs and Drug Delivery Options for Glaucoma Management
It was a pleasure to speak with Sarah Van Tassel (Weill Cornell Medicine, NY, USA) on her thoughts about the new therapeutic options for glaucoma management and the promising new combinations on the horizon. How has the pharmaceutical landscape for glaucoma developed in the last year? (00:12) Where do rho-kinase inhibitors sit in the treatment […]
Thomas V Johnson, AGS 2021: Current Status and Future Challenges of Stem Cell-based Retinal Ganglion Cell Transplantation in Glaucoma Therapy
We were delighted to speak with Dr Thomas V Johnson (Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA) and find out his thoughts on the current status and future challenges of stem cell-based retinal ganglion cell transplantation in glaucoma therapy, and the challenges and opportunities of the online format of this year’s virtual meeting. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!